Close Menu

NEW YORK (GenomeWeb) — Stemina Biomarker Discovery announced today that it has initiated a clinical study examining metabolism biomarkers for autism spectrum disorder (ASD) with the support of a $2.7 million grant from the National Institutes of Health.

Also funding the study is a $2.3 million investment from the Nancy Lurie Marks Family Foundation that Stemina received last year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.